Companies: 10,795·Total market cap: $144.5T
Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

WVENASDAQHealthcare● Active
$5.81
+$0.08(+1.48%)
Market Cap$1.1B
P/E Ratio
52W High$21.73
52W Low$5.02

Wave Life Sciences Ltd. (WVE) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

wve · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 25 Wall Street analysts in the past 3 months

SellBuy

Buy

25 analysts

consensus

Rating Breakdown

Strong Buy
1
Buy
23
Hold
1
Sell
0
Strong Sell
0
Total: 25 · Buy rate: 96.0%

12-Month Price Target

High

$43.00

Consensus

$26.38

+353.7% upside

Low

$13.00

Median: $28 · Last Close: $5.82

The Wave Life Sciences Ltd. (WVE) analyst consensus is Buy, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month WVE price target is $26.38, representing +353.7% upside from the current price of $5.82.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $26 (353.7%)

Consensus Target

$26.38

353.7% upside

High Target

$43

639.5%

Low Target

$13

123.6%

Current Price

$5.82

as of today

Based on analyst price targets, the WVE stock price prediction for the next 12 months ranges from $13 to $43. The consensus WVE price forecast of $26.38 implies 353.7% upside from the current price of $5.82.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$5.525.00%

1-day model range: $5.49–$5.56. Peak: $5.56 (-5.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%36%64%
0Buy
5Neutral
9Sell
RSI (14)38.7Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · WVE · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$5.82SELL
MA 10$6.11SELL
MA 20$6.36SELL
MA 50$6.86SELL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $WVE · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.90SELL
EMA 10$6.06SELL
EMA 20$6.31SELL
EMA 50$6.83SELL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $WVE · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Wells Fargo2026-05-20
Maintains
OverweightOverweight
HC Wainwright & Co.2026-05-19
Maintains
BuyBuy
Citigroup2026-05-04
Maintains
BuyBuy
Canaccord Genuity2026-04-30
Maintains
BuyBuy
Truist Securities2026-04-29
Maintains
BuyBuy
HC Wainwright & Co.2026-04-14
Maintains
BuyBuy
B of A Securities2026-03-27
Maintains
BuyBuy
Wells Fargo2026-03-27
Maintains
OverweightOverweight
Mizuho2026-03-25
Maintains
OutperformOutperform
Canaccord Genuity2026-03-10
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Wave Life Sciences Ltd. (WVE) stock. Of the recent 83 rating actions, 3 were upgrades and 1 were downgrades. 25 analysts currently cover WVE.

Analyst Recommendation Trends

Buy ratings23↑ +1
Hold ratings00
Sell ratings00

WVE analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$58M

↓ 49.4% YoY

Revenue Next Year

$56M

↓ 2.6% YoY

EPS This Year

$-1.11

EPS Next Year

$-1.29

↑ 16.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast WVE EPS of $-1.11 for the current fiscal year, based on estimates from 11 analysts. The WVE revenue forecast is $58M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The WVE stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus WVE price target is $26.38 (+353.7% upside), with an analyst consensus of Buy.

The WVE short-term stock prediction for tomorrow is $5.52 (-5.00%).

Wave Life Sciences Ltd. trades on NASDAQ under the ticker WVE. The WVE stock outlook for 2027 is broadly positive, supported by a Buy consensus among 96% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

WVE forecast · 8 questions

According to 25 Wall Street analysts, the average 12-month WVE price target is $26.38, with a high forecast of $43.00 and a low of $13.00. The median price target is shown in the chart above when available. This implies +353.7% potential upside from the current price of $5.82.

WVE price targetWhat is WVE price targetWVE analyst price targetWVE 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.